🔎 Trials Near Me

Home › Crohn's Disease › Connecticut › Hartford

Crohn's Disease clinical trials in Hartford, CT

5 studies for Crohn's Disease are looking for participants at sites in and around Hartford (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

RecruitingPhase 3
  • Connecticut Children's Medical Center, Hartford
Ages 2 to 19 · All sexes · Updated Sep 22, 2026 · NCT04844606

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

RecruitingPhase 3
  • Connecticut Children's Medical Center, Hartford
Ages 2 to 17 · All sexes · Updated Aug 24, 2026 · NCT05509777

Assessment and Educational Intervention to Reduce Ultra-processed Food Consumption in Pediatric Patients With IBD

RecruitingObservational studyHealthy volunteers welcome
  • Connecticut Children's Medical Center, Hartford
Ages 10 to 21 · All sexes · Updated Jul 16, 2026 · NCT07224113

Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease

RecruitingPhase 3
  • Connecticut Children's Medical Center - Hartford /ID# 262256, Hartford
Ages 2 to 17 · All sexes · Updated Jun 24, 2026 · NCT06332534

Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

RecruitingPhase 4
  • Connecticut Children's Medical Center, Hartford
Ages 6 to 17 · All sexes · Updated May 27, 2026 · NCT05781152

About Crohn's Disease

Crohn's Disease can cause inflammation in any area from the mouth to the anus. Read about medicines, surgery or dietary management to treat symptoms.

More about Crohn's Disease on MedlinePlus

Crohn's Disease trials in other cities

Other studies in Hartford

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.